NO970676L - Nye pseudopeptider avledet fra neurokininer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye pseudopeptider avledet fra neurokininer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO970676L
NO970676L NO970676A NO970676A NO970676L NO 970676 L NO970676 L NO 970676L NO 970676 A NO970676 A NO 970676A NO 970676 A NO970676 A NO 970676A NO 970676 L NO970676 L NO 970676L
Authority
NO
Norway
Prior art keywords
neurokinins
novel
preparation
methods
pharmaceutical compositions
Prior art date
Application number
NO970676A
Other languages
English (en)
Norwegian (no)
Other versions
NO970676D0 (no
Inventor
Jean-Luc Fauchere
Nathalie Kucharczyk-Gentric
Emmanuel Canet
Michel Lonchampt
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO970676D0 publication Critical patent/NO970676D0/no
Publication of NO970676L publication Critical patent/NO970676L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO970676A 1996-02-16 1997-02-14 Nye pseudopeptider avledet fra neurokininer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO970676L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9601919A FR2745003B1 (fr) 1996-02-16 1996-02-16 Nouveaux pseudopeptides derives de neurokinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO970676D0 NO970676D0 (no) 1997-02-14
NO970676L true NO970676L (no) 1997-08-18

Family

ID=9489264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970676A NO970676L (no) 1996-02-16 1997-02-14 Nye pseudopeptider avledet fra neurokininer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (16)

Country Link
US (1) US5708016A (da)
EP (1) EP0790254B1 (da)
JP (1) JPH09227554A (da)
CN (1) CN1164537A (da)
AT (1) ATE204582T1 (da)
AU (1) AU713096B2 (da)
CA (1) CA2197611A1 (da)
DE (1) DE69706206T2 (da)
DK (1) DK0790254T3 (da)
ES (1) ES2163104T3 (da)
FR (1) FR2745003B1 (da)
GR (1) GR3037045T3 (da)
NO (1) NO970676L (da)
NZ (1) NZ314238A (da)
PT (1) PT790254E (da)
ZA (1) ZA971267B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653304B2 (en) * 2000-02-11 2003-11-25 Bristol-Myers Squibb Co. Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
WO2002000646A1 (en) * 2000-06-27 2002-01-03 Smithkline Beecham Corporation Fatty acid synthase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK65094A3 (en) * 1992-09-03 1995-03-08 Boehringer Ingelheim Kg Aminoacid derivatives, process for producing the same and pharmaceutical compositions containing these derivatives
FR2719312B1 (fr) * 1994-04-28 1996-06-14 Adir Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DK0790254T3 (da) 2001-10-08
NZ314238A (en) 1997-12-19
AU713096B2 (en) 1999-11-25
JPH09227554A (ja) 1997-09-02
CA2197611A1 (fr) 1997-08-17
CN1164537A (zh) 1997-11-12
ATE204582T1 (de) 2001-09-15
DE69706206D1 (de) 2001-09-27
DE69706206T2 (de) 2002-05-23
EP0790254B1 (fr) 2001-08-22
AU1266097A (en) 1997-08-21
PT790254E (pt) 2001-11-30
NO970676D0 (no) 1997-02-14
ZA971267B (en) 1997-08-27
FR2745003A1 (fr) 1997-08-22
FR2745003B1 (fr) 1998-04-03
EP0790254A1 (fr) 1997-08-20
ES2163104T3 (es) 2002-01-16
GR3037045T3 (en) 2002-01-31
US5708016A (en) 1998-01-13

Similar Documents

Publication Publication Date Title
DE69406649D1 (de) N-alkyl-2-substituierte atp-analoge
NO20021859D0 (no) Nye digosakkarider, deres fremstilling samt farmasöytiske preparater
ES2188194T3 (es) 1,8-naftiridin-4(1h)-onas sustituidas como inhibidores de la fosfodiesterasa 4.
HK1076107A1 (en) Pyrrolidine derivatives as oxytocin antagonists
DK0992509T3 (da) Nye makrolid-derivater
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
DE69323712D1 (de) Indol derivate zur behandlung von migräne
EG20726A (en) Process for preparing of galanthamine derivatives as acetylchol inc-sterase inhibitors
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина
NO970676D0 (no) Nye pseudopeptider avledet fra neurokininer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
NO972943L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse
DE60335960D1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
NO20011038L (no) Substituerte dihydrobenzopyraner nyttige som antiarytmiske midler
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
EA200000922A1 (ru) Производные аминоантрациклинона и их применение в лечении амилоидоза
ATE265453T1 (de) Diketopiperazinderivate als thrombininhibitoren
DK0697404T3 (da) Nye, enantiomerrene pyridylcycloalkylethylaminer og deres salte, såvel som fremgangsmåder til deres fremstilling
ECSP003488A (es) Derivados de 13- metileritromicina
DE69724130D1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl protein transferase inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application